Peri-TACE STRIDE plus lenvatinib improved progression-free survival versus TACE alone in a randomized, open-label, sponsor-blinded global phase 3 population. Interim overall survival analysis showed a ...
Patients with intermediate stage primary liver cancer who received a vaccine of dendritic cells saw a longer time without tumour progression in response to standard treatment according to a new study ...
Please provide your email address to receive an email when new articles are posted on . Alcohol is not the only cause of liver cancer; HBV, HCV and fatty liver disease are also risk factors. Awareness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results